Pharmaceuticals

Police arrest two suspects during Gurugram fake Mounjaro racket bust, with seized counterfeit injections and Rs 71 lakh cash on display.

Gurugram fake Mounjaro racket busted: Two arrested, Rs 71 lakh seized, nationwide alert issued

20. huhtikuuta 2026 Raportoinut AI AI:n luoma kuva

Gurugram's Drugs Control Office busted a counterfeit Mounjaro (tirzepatide) injections racket on April 18, arresting Avi Sharma and Mujammil Khan after intercepting a cab in DLF Phase-IV and raiding Sharma's flat. Fake injections worth over Rs 71 lakh were seized, with packaging machines recovered. A nationwide alert has been issued, and officials warn of health risks from such fakes.

Semaglutide shows strong weight loss results for adults over 65

A new analysis of clinical trials indicates that semaglutide, the active ingredient in Ozempic and Wegovy, helps older adults with obesity lose substantial weight and improve heart health markers. The findings come from data on participants aged 65 and above who received the once-weekly medication alongside lifestyle changes.

Acadia Pharmaceuticals publishes 2026 Q1 earnings slide deck

06. toukokuuta 2026 Raportoinut AI

Acadia Pharmaceuticals Inc. released a slide deck for its first-quarter 2026 earnings call on May 6.

Afrikka

Egypt and Sweden explore expanding pharmaceutical cooperation

Liiketoiminta

Syntara reports positive FDA feedback on amsulostat trial

Terveys

University of Utah researchers identify enzyme PapB that can “lock” GLP-1-like peptides into ring structures

Egypt and Kenya deepen health and pharmaceutical cooperation at Nairobi summit

Egyptian Health Minister Khaled Abdel Ghaffar met Kenyan Health Minister Aden Bare Duale on the sidelines of the Global Health Summit in Nairobi to explore expanding cooperation in healthcare and pharmaceuticals. Discussions focused on transferring Egyptian expertise and fast-tracking pending strategic agreements. The initiative underscores Egypt's commitment to continental health security.

Sun Pharma shares jump over 9% on $11.75 billion Organon acquisition

26. huhtikuuta 2026 Raportoinut AI

Sun Pharmaceutical Industries' shares surged more than 9% following the announcement of its $11.75 billion acquisition of US-based Organon & Co. The deal targets bolstering the Indian company's innovative medicines and positioning it strongly in biosimilars and women's health markets. Organon is recognized as a global leader in women's health.

ISP orders voluntary recall of loratadine syrup due to impurities

Chile's Public Health Institute (ISP) issued a pharmaceutical alert ordering the voluntary recall of Laboratorio Chile S.A.'s loratadine syrup 5 mg/5 ml after detecting out-of-specification impurities in stability studies. The action targets batches EWOA, EWOB, and EWOC, expiring in September 2026.

Egypt's PM Madbouly reviews strategic medicine stocks and raw materials

29. maaliskuuta 2026 Raportoinut AI

Egypt's Prime Minister Mostafa Madbouly chaired a high-level meeting on Sunday to review the availability of pharmaceutical products and active raw materials in the domestic market. The session, attended by ministers and officials, emphasized ensuring adequate strategic drug reserves and monitoring supply chains while advancing localization efforts. A detailed report confirmed sufficient inventories to meet local demand.

5. toukokuuta 2026 05.13